During the past decade, Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica" are "Ovarian Cancer" (3 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica" in a lesser frequency.

Most popular intervention types in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (3 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica" are 6 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".